Sign inGet started

Kakkar Rahul

Insider CIK 1817416 · PAND Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PAND Pandion Therapeutics, Inc. D To issuer deriv2021-04-012021-04-01348,741— $00SEC↗
PAND Pandion Therapeutics, Inc. D To issuer deriv2021-04-012021-04-01221,367— $00SEC↗
PAND Pandion Therapeutics, Inc. U Tender2021-04-012021-04-01702,515$60.00 $42.15M0SEC↗
PAND Pandion Therapeutics, Inc. U Tender2021-04-012021-04-0114,000$60.00 $840.0K0SEC↗
PAND Pandion Therapeutics, Inc. A Award deriv2021-02-082021-02-10221,367— $0221,367SEC↗
PAND Pandion Therapeutics, Inc. C Conversion deriv2020-07-212020-07-21107,768— $00SEC↗
PAND Pandion Therapeutics, Inc. C Conversion2020-07-212020-07-2121,133— $0702,515SEC↗
PAND Pandion Therapeutics, Inc. P Buy2020-07-212020-07-2114,000$18.00 $252.0K14,000SEC↗
PAND Pandion Therapeutics, Inc. A Award deriv2020-07-172020-07-21100,493— $0100,493SEC↗
PAND Pandion Therapeutics, Inc. A Award deriv2020-07-172020-07-2127,181— $027,181SEC↗
PAND Pandion Therapeutics, Inc. A Award deriv2020-07-172020-07-21221,067— $0221,067SEC↗